Healthcare
Ted Cruz denies reporter’s request to wear a mask: ‘You’re welcome to step away if you’d like’
Sen. Ted Cruz (R–Texas) denied a reporter’s request that he wear a mask during a press conference on Wednesday.
While speaking at the Russell Senate Office Building in Washington D.C., a reporter asked Cruz, “Would you mind putting on a mask for us?”
Cruz replied, “Uh, when I’m talking to the TV camera I’m not going to wear a mask,” adding that all his Senate colleagues have been immunized against COVID-19.
“It would make us feel better,” the reporter said.
“You’re welcome to step away if you’d like,” Cruz said. “The whole point of the vaccine — CDC guidance is what we’re following.”
Cruz later tweeted, “Lefty reporters have lost their minds. #commonsense.”
Cruz was speaking to reporters about the upcoming Congressional Delegation trip to the southern border on Friday.
Republican representatives have organized a trip to the border to hear directly from individuals affected by the border crisis.
Cruz will be joining Rep. Jim Jordan (R-OH) and Rep. Tom McClintock (R-CA) on the trip and they have extended the offer to the Democratic lawmakers in a letter addressed to Chairman Jerry Nadler on Wednesday.
Follow Annaliese Levy on Twitter @AnnalieseLevy
Tennessee Republican Representative Diana Harshbarger is attempting to fight the opioid crisis and epidemic through new legislation. Introduced Friday, Harshbarger told the Daily Caller:
The Daily Caller first obtained a copy of the legislation, which addresses what Harshbarger calls a “loophole.” The legislation amends the Controlled Substances Act to specifically require registrants to investigate reports of suspicious orders of controlled substances and halt them if necessary. Under the version of the act currently in force, drug manufacturers and distributors are only required to report suspicious orders of opioids and other controlled substances to the DEA.
“Breaking the opioid epidemic’s stranglehold on our nation is one of my foremost priorities. In an effort to do so, my colleagues and I have identified a loophole that allows distributors to continue order fulfillment, even under suspicious circumstances.”
“My bill closes that loophole with the requirements and guardrails needed to ensure these addictive and potentially dangerous drugs do not fall into the wrong hands while the DEA investigates. The future of our nation depends on us solving the addiction crisis, and this is a step towards that outcome” Harshbarger continued.
The Daily Caller reports:
According to a congressional report released in September, the opioid crisis cost the U.S. $1.5 trillion during the COVID-19 pandemic.
The CDC says 93,331 people died from overdoses in the U.S. in 2020, the highest in 50 years. Opioid-related deaths made up nearly three-quarters of the total.
Pharmaceutical companies have been blamed for contributing to the opioid epidemic. The Department of Justice is currently suing the pharmaceutical company AmerisourceBergen over allegations the company failed to report suspicious orders of opioids to federal law enforcement.
-
Politics4 days ago‘Coordinated effort’ to hide Hunter Biden information: Treasury denies request for reports
-
Elections4 days agoJudge orders Biden’s DHS to release files on agents accused of censoring election ‘misinformation’
-
Immigration20 hours agoMigrants refuse to go to Brooklyn cruise terminal shelter, return to Manhattan hotel
-
Immigration7 days agoNYC Mayor turning cruise ship terminal into migrant shelter, ‘our city is at its breaking point’
